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THE ORIGIN OF MAN'S INTEREST IN HEPATIC 
REGENERATION 
The first mention of hepatic regeneration can be traced to the Greek 
legend of Prometheus, which was developed centuries before the birth of 
Christ (Esiodo, B.c.). However, it was only toward the end of the 19th 
century that the first experimental observations performed on laboratory an-
imals were reported demonstrating complete restoration of hepatic mass fol-
lowing either a partial hepatectomy or a sublethal hepatic injury induced by 
chloroform (Von Podwyssozki. 1886; Ponfick, 1890). 
A landmark event in the field of hepatic regeneration occurred when 
Higgins and Anderson (1931) standardized the procedure of partial hepatec-
tomy (PH) using the rat. As a means of experimentally examining the process 
of liver regeneration, this model rapidly became the most frequently utilized 
in vivo system for such studies and the characterization of factors responsible 
for and controlling hepatic regeneration. The second series of landmark 0b-
servations in this field were the experiments of Christensen (Christensen and 
Iacobsen 1949), Bucher et at. (1951), and Fisher (Fisher el al. 1971) who 
all utilized parabiotic rats, and the studies of Leong et al. (1964) and Segal 
et at., (1968) who used autografts in which the factors initiating the process 
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of hepatic regeneration were found to be blood borne. Earlier experimental 
~tudies by Teir and Ravanti (1953) and Blomqvist (1957). in which homog-
~nates of regenerating liver were used as a reagent source. suggested that the 
factors initiating hepatic regeneration might be synthesized by the fiv~r itself. 
These observations led to a variety of theories concerning the regulation of 
~epatic regeneration. The most important of these suggested the existence of 
both growth stimulating factors (GSFs) (Blomqvist, 1957; Marshak and Walker. 
1945; Teir. 1952; Paschkis, 1958) and growth inhibiting factors (G1Fs; (Weiss. 
1952; Weiss. 1955; Weiss and Kavanau. 1957; Smythe and Moore. 1958; 
Stich and Florian. 1958; G1inos. 1958; Bullough. 1962). With these concepts 
in mind. many attempts have been made to isolate both GSFs (LaBrecque 
and Pesch. 1975; Starzl et al.. 1979; Terblanche et aI .• 1980; MichaJopoulos 
et aI., 1984; Nakamura et al.. 1984; Goldberg, 1985; Schwarz et aI., 1985; 
Fleig et al.. 1986; Diaz-Gil et al.. 1986; Gohda et aI., 1986; Francavilla et 
al.. 1987) and hepatic GIFs (Chany and Frayssinet. 1971; Chopra and Simnett, 
1971; Verly et aI .• 1971) from a wide variety of sources and tissues. 
The major alternative hypotheses to the concept of GSFs and G1Fs con-
cerning the regulation of hepatic regeneration were (I) the metabolic overload 
theory (Goss. 1964; Alston and Thomson. 1966), in which the liver was 
believed to increase its mass to satisfy a specific need. and (2) the blood now 
theory. in which the amount of blood delivered to the liver, particularly via 
the portal vein. determined the hepatic mass (Mann, 1944; Child et al.. 1953; 
Fisher et al.. 1967; Weinbren et aI., 1972; Weinbren et aI., 1975). Numerous 
studies. in particular those directed at assessing the latter hypothesis. led to 
the recognition of insulin as an important hepatotrophic substance responsible 
for liver regeneration. The widespread development and use of various por-
tacaval-shunt (PCS) animal models has confirmed the importance of insulin 
as an important growth regulating substance in determining the degree of 
hepatic regeneration (Starzl et al.. 1973. 1975a. and 1976) and represents a 
third landmark in the long history of hepatic regeneration and its control. 
Following the recognition of insulin as an important hepatic growth factor, 
several other hormones were also shown to have some effect. albeit less than 
that of insulin in stimulating liver regeneration (Leffert et al.. 1975. 1979; 
Richman et al.. 1976; McGowan et al.. 1981). In particular, Leffert et al. 
(1979) emphasized the role of blood-borne hormones as being critical for the 
induction of hepatocellular proliferation and suggested that hepatic regener-
ation was controlled by a "concerted endocrine regulation" (McGowan et 
al.. 1981; Bissell. 1976). 
In the mid-1970s. the development of primary hepatocyte cultures pro-
vided an important new in vitro model for the study of hepatic regeneration 
under highly controlled laboratory conditions (Leffert et aI .• 1978; Maher. 
1988). Using cell culture systems. it was quickly noted that the processes 
regulating liver cell growth observed in vivo and those noted in vitro were 
different,presumably because liver cells in culture lack the complex inter-
actions which occur in vivo between hepatocytes and nonparenchymal cells 
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(NPC) (Guguen-Guillouzo et aI., 1983, 1984; Begue et aI., 1984; Clement 
et al.. 1984; Fraslin et al.. 1985; Morin and Normand. 1986). Subsequent 
studies have demonstrated that critical interactions also occur between liver 
cells and the matrix upon which the liver cells are plated (Rojkind et aI., 
1980; Reid et al.. 1986; Sawada et aI .• 1986; Bissell et aI .• 1987; Schuets et 
aI .• 1988; Bissel and Choun. 1988), and that these interactions influence the 
functionaI and replicative activity of hepatocytes maintained in culture (Bissel 
and GuzeIian. 1980; Ichiara et al.. 1980; Guguen-Guillouzo and Guitlouzo, 
1983b; Crane and Miller. 1983; Jefferson et aI., 1985; Nawa et a\., 1986; 
Hutson et al.. 1987; Aaim et al.. 1987; Lloyd et aI., 1987). 
In the 1980s the techniques of molecular biology had allowed investi-
gators to define more clearly the molecular events occurring within prolif-
erating hepatocytes. i.e .• alterations in oncogene expression. the timing of 
transforming growth factor-a and -13 (TGF-a. and -13) production and both 
qualitative and quantitative changes in the intracellular content of proteins 
important in the process of cell growth and replication as assessed by quan-
titation of their specific mRNAs (Atryzek and Fausto. 1979; Fausto and Shank. 
1983. 1987; Fausto, 1984; Mead and Fausto. 1989; Fausto and Mead. 1989). 
Most recently. new data concerning liver regeneration in man and the 
relationship between the immune system and hepatic growth control have 
been added to the knowledge base. 
The major factors regulating the regenerative response of the liver in man 
are similar to those known to regulate hepatic regeneration in animals. The 
differences between man and animals relate to the timing of specific events 
(Francavilla et al.. 1989a. 1990a). 
The immunosuppressive drugs. cyclosporine (CyA), FK 506, and rapa-
mycin (RPM), which modify signal transmission in cells of the immune 
system, also modulate the process of hepatic regeneration (Makowka et al.. 
1986; Francavilla et a!.. 1989, 1992a). 
KINETICS OF HEPATIC REGENERATION 
Under normal circumstances, the proliferative activity of hepatocytes in 
adult animals is very low. and only a few cells can be shown to proliferate. 
These cells are typically found near the portal tracts (Harkness. 1952; Gris-
ham. 1962; Fabrikant. 1967; Verly, 1976). closer to the incoming portal blood. 
Under basal conditions the labeling index of hepatocytes 2 h after an i.p. 
administration of ['HJ-thymidine in rats is about 0.3% (Grisham. 1962; Schultze 
and Oehlert, 1960; Edwards and Koch. 1964). In dogs, this value falls to 
0.16% (Francavilla et a!.. 1978). Under steady-state conditions nonparen-
chymal cells have an even lower proliferation rate than that observed for 
hepatocytes. In fact, after 60 h of continuous administration of ('H)-thymidine 
under basal conditions, Kupffer cells and endothelial cells have a labeling 
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index of only 3 and 7%, respectively (Volkman, 1977; Crofton et aI., 1978; 
Bouwens et al., 1986). 
This situation changes dramatically, however, when a surgical resection 
or hepatic injury, induced either by a viral illness or chemical injury reduces 
the functional mass of the liver. Following each of these processes, residual 
liver cells experience an enhanced proliferative response, the magnitude of 
which varies as a function of the amount of hepatic mass lost as a result of 
the prior injury. This phenomenon is referred to as hepatic regeneration. This 
term is also widely used to refer to the process which occurs after a partial 
hepatectomy but, in this case, should more properly be described as com-
pensatory hepatic hyperplasia because the excised hepatic lobes do not actually 
grow back. Instead. the residual liver mass undergoes a hyperplastic reaction 
which compensates for the lost tissue (Weinbren, 1959). 
During the regenerative response that follows any major hepatic injury. 
virtually all of the surviving hepatocytes undergo mitosis. In fact, if the 
residual liver of a partially hepatectomized rat is infused with PHI-thymidine 
for the 7 to 8 d required for the hepatic mass to be restored fully, 95% of the 
liver cells will be found to contain the label (Fabrikant. 1969; Tsanev. 1975; 
Wright and Alison, 1984; Fausto, 1990; Farber. 1956; Lombardi. 1982; Fausto 
et a!. 1986; Sell, 1990). 
In rats. the hepatic regenerative response following partial hepatectomy 
starts in an almost synchronous manner in the peripheral part of the lobule. 
producing a peak of DNA synthesis after about 20 h. Almost all the remaining 
hepatocytes of the lobule progressively proliferate, generating a sort of wave-
like front of DNA synthesis moving toward the central vein (Bucher and Malt, 
1971; Rabes et al., 1975). This observation suggests that under physiologic 
conditions resting liver cells are arrested in the Go phase of the cell cycle 
(Tsanev. 1975; Wright and Alison. 1984; Farber. 1956; Lombardi, 1982; 
Fausto et a!.. 1986; Bucher and Malt, 1971). 
In rats following a partial hepatectomy, hepatocyte DNA synthesis starts 
after a lag phase of 12 h and reaches a peak within 24 h. In contrast, the 
peak mitotic activity of nonparenchymal cells is delayed, and occurs at 48 
and 96 (Widmann and Fahimi, 1975). 
A post-hepatectomy-induced proliferative response leads to full restora-
tion of the hepatic mass in rats in about 10 d. For larger animals and man. 
full restoration of hepatic mass requires a longer period of time. i.e .• 2 and 
3 weeks, respectively (Fausto et al.. 1986; Van Thiel et aI., 1985; Bucher 
and Malt, 1971). 
The kinetics of the regenerative process described above are those ob-
served in young adult animals. In weanling rats. the peak of DNA synthesis 
is achieved 3 h earlier. while in older rats it is delayed by about five h (Bucher 
et aI., 1964). Moreover. a regenerative response occurs only when at least 
30% of the liver mass is removed in young adult rats. In very young and in 
aged rat~K a 10% reduction in hepatic mass suffices to trigger a regenerative 
response probably because the functional reserve of the liver is different for 
each of these age groups (Bucher et al.. 1964; Bucher, 1967). The proliferative 
response is influenced also by the feeding or light exposure pattern of the 
animal as both of these factors modulate the circadian rhythms of the animals 
(Bucher and Malt, 1971). 
i ' 
CONTROL FACTORS IN HEPATIC REGENERATION 
The nature of the various factors involved in the process of liver prolif-
eration is addressed in the next section of this review. Subsequently an attempt 
is made to define the relationships between these factors and the observed 
hepatic regeneration. 
Hormones 
Numerous changes in circulating hormone levels have been reported in 
rats following PH (Leffert et aI., 1975, 1979; Bucher and Malt, 1971; Echave-
Llanos et aI., 1971; Thrower and Ord, 1974; Leffert and Alexander, 1976; 
Bucher and Weir. 1976; Leffert. 1977; Bucher et al.. 1978a; Royse and 
Morley, 1984). Many of these changes have been characterized and appear 
to correlate with measurable alterations in the hepatocyte expression of re~ 
ceptors forthese hormones (Leffert et aI., 1975; Porter et aI., 1984; Francavilla 
et al.. 1984. 1986a; Eagon et aI., 1985; Cruise et aI., 1989). However, in 
vitro only some of the hormones can be shown to amplify the proliferative 
response when added to a culture system containing medium with growth 
factors (Richman et al.. 1976; McGowan et aI., 1981; Michalopoulos et al .• 
1982; Russell and Bucher. 1983; Cruise et a!., 1985; Francavilla et al.. 1986b; 
Takai et aI., 1988). 
Insulin and Glucagon 
The role of insulin and glucagon in the control of hepatic regeneration 
has been the subject of numerous studies utilizing a wide variety of different 
experimental models. The one that has contributed the most to the current 
understanding of the relationship between pancreatic hormones and hepatic 
regeneration is the splanchnic flow division model of Starzl et al. (1973) 
(Figure I). In short, the two portal vein branches are isolated. One is left 
undisturbed while the other is detached and anastomosed by means of an iliac 
vein graft to the common mesenteric vein below the level of the splenic and 
pancreatic venous input. Functionally this model splits the liver into two 
distinct areas: the left lobe, which receives portal blood rich in pancreatic 
hormones, and the right lobe. which receives blood from the intestine. Table 
I shows the changes in terms of glycogen and cyclic adenosine-5' -mono-
phosphate (cAMP) content of the two sides of the liver 2 months after such 
a shunting procedure has been performed. The lobe perfused with nutrient-
rich intestine venous blood becomes atrophic, while the contralateral lobe 
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Flpre 1. Schematic representation of division of splanchnic venous flow into a pancreatico· 
gastroduodenal-splenic compartment and an intestinal compartment. 
TABLE 1 
The Effect in Splanchnic Division Experiments of Perfusing the Liver 
with Pancreatic Duodenal Splenic vs. Intestinal Blood 
p~lanchnic Flow to Left Lobes (2 months) 
Glycogen. mglg of liver 
Total 
Trichloroacetic acid. soluble 
Cyclic adenosine monophos-
phate. pmollg of liver 
Phosphorylase. nmmollminlmg 
of liver protein 
Total 
Active 
Glucokinase ..... mollglmin 
Protein concentration. mglg of 
liver 
Protein synthesis. cpm/g of 
liver 
Note: NS. not significant. 
No. 
6 
6 
6 
6 
6 
4 
6 
3 
RighI 
2.83 ± 1.87 
2.00 ± 1.31 
1077 ± 237 
121.2 ± 13.2 
49.2 ± 7.9 
2.07 ± 1.13 
192.7 ± 33.1 
2340 ± 970 
Left P 
4.07 ± 1.64 <0.01 
3.23 ± 1.41 <0.001 
1164 ± 218 <0.1 
113.2 ± 11.6 NS 
48.5 ± 7.3 NS 
2.67 ± 0.88 NS 
198.2 ± 33.9 NS 
2509 ± 341 NS 
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which is supplied with pancreatic honnone-rich portal venous blood maintains 
an almost nonnal appearance. In addition. the laller has an increased number 
of liver cells undergoing mitoses (Starzl et at.. 1973). These differences 
between the two lobes disappear when the animal is made diabetic with alloxan 
(Stanl et al .• 1975a. b. and d). Additional evidence for an important role 
played by insulin in the process of hepatic regeneration include: (I) the 
regenerative response following PH is reduced when anti-insulin antibodies 
are injected into portal venous blood (Thrower and Ord, 1974) and (2) the 
administration of insulin to rats with experimental diabetes causes an increase 
in the number of mitoses found in the liver which returns to a level similar 
to that observed after a partial hepatectomy in nondiabetic nonnal animals 
(Yaunger et al.. 1966). 
Despite this considerable experimental evidence. the precise role of in-
sulin in the process of hepatic regeneration remains controversial: (I) insulin 
does not stimulate hepatocyte proliferation in vitro (Leffert et al.. 1979; 
Michalopoulos et al.. 1982; McGowan et al.. 1981). (2) the effect of insulin 
on hepatocyte proliferation appears to depend upon its metabolic effects. (3) 
the difficulties encountered in defining the role of glucagon, either alone or 
in conjunction with insulin. as a hepato-proliferative factor (Simek et al.. 
1967; Bucher et al.. 1977; Caruana et aI., 1981). 
Nonetheless, the introduction of the portacaval shunt model of Stanl et 
aI., that is a further development of the Eck fistula (Figure 2) (Stanl et aI., 
1976. 1983) has contributed substantially to define the role of insulin in vivo 
in modulating hepatocyte proliferation. After a portacaval anastomosis. the 
liver becom~ remarkably atrophic despite the fact that the number of pro-
liferating hepatocytes (those with mitosis) within the liver increases from 
0.16% of the tOlalto a value of 0.47%. This change in mitotic activity occurs 
within 48 h and persists indefinitely in the dog. Importantly. this level of 
proliferative activity is comparable to that obtained in a dog 72 h after a 40% 
hepatectomy (Francavilla et aJ.. 1978). 
Infusion of minute quantities of either honnones or growth factors in 
either one of the two lobes over a 4-d period results in a restoration of cell 
size. cell ultrastructural appearance. and an increase in the number of mitotes 
only in the infused lobe (Starzl et a!.. 1976. 1983; Francavilla et al.. 199Ia). 
The advantages of this unique model are 
I. There is no biological variability within the experimental and control 
groups because by splitting the liver into two experimental parts every 
animal becomes its own control. 
2. The effect of both growth stimulating and growth inhibiting substances 
can be assessed with the model. 
3. The method has a high degree of reproducibility and sensitivity (I to 
100 nglkg/d of either growth factors or honnones are able to produce 
a biological response in the perfused hepatic lobe). 
H , : i I 
,! 
• .110 ltJUtc..LUlUI U/tU LLU ierfr~F UJ Utt iA~t:1 
Pump 
Substance 
Tested 
FIgure 2. Portacava shunt model. The shunt is obtained by a large side-to-side anastomosis 
between the portal vein and the inferior vena cava and completely diverting portal blood by 
tieing off the main right and left portal trunks. The tip of a fine infusion catheter is then placed 
into the tied-off left portal branch and led through the body wall and through a long subcutaneous 
tunnel to a battery-driven automatic pump placed into an animal jacket. The solutions to be 
tested are infused in the left portal branch at the rate of 25 mild, for 4 d, beginning just after 
the intervention. 
TABLE 2 
Effect of Insulin and/or Glucagon Infusion on Cell Division in PCS 
No. of Labeled HepatocytesllOOO 
Insulin Dose Glucagon Dose ee~atoc~tes (mean ± S.D.) 
Group (JI.S/kgld) (mglkgld) p Values 
No. (mean ± S.D.) (mean ± S.D.) Left Right L vs. R 
1 0'" 0'" 4.6 ± 0.8 4.7 ± 0.9 NS 
2 0.42 0 13.0 ± 3.9 4.6 ± 0.9 <0.001 
3 0 0.60 4.2 ± 1.5 4.3 ± 1.1 NS 
4 0.45 0.0053 11.8 ± 1.2 4.5 ± 0.8 <0.001 
5 0.42 0.50 14.8 ± 1.0 4.5 ± 0.3 <0.001 
kot~: NS, no significance. 
Table 2 shows the results obtained by infusing pancreatic hormones into 
the left lobe of the liver of dogs with such a PCS (Starzl et aI., 1976). Unlike 
glucagon, which has no effect even in large unphysiologic doses, insulin 
stimulates hepatocyte proliferation at physiologic Ivels. Importantly, the 
I 
-', I 
simultaneous administration of insulin and glucagon does not alter the response 
from that observed with insulin alone. 
Sex Steroid Hormones 
The relationship between sex steroid hormones and liver cell proliferation 
has been examined in the last several years, both at a basic cellular level and 
at the macroscopic clinical level. Several neoproliferative hepatic diseases 
such as adenomas and angiosarcomas have been reported to occur in asso-
ciation with either endogenous or exogenous hyperestrogenism (Baum et aI., 
1973; O'Sullivan and Wilding, 1974; Ameriks et aI., 1975; Sherlock, 1975; 
Christopherson et aI., 1975; Glassberg and Rosenbaum, 1976; Neuberger et 
aI., 1980; Wanless and Medline, 1982). The uniqueness of these observations 
is the fact that such neoproliferative hepatic diseases have never been described 
to occur in association with hyperinsulinism, hyperthyroidism, or any other 
condition recognized as modulating circulating levels of factors known to 
affect liver cell proliferation either in vitro or in vivo. Moreover, estrogens 
appear to modulate both normal and neoplastic proliferation in other organs 
of the digestive tract (Polimeno et al., submitted; Sica et aI., 1984). 
The relation between liver regeneration and steroidal sex hormones has 
been studied extensively using the PH rat model. Following a PH, striking 
alterations in the blood levels of sex hormones occur and accompanying 
changes in the hepatic content of sex hormone receptors appear within the 
liver (Figure 3). Serum estradiol levels increase, while the hepatic content of 
~ receptors also increases. In contrast, serum androgen levels decline in 
concert with a rapid disappearance of androgen receptors within the liver. 
These changes in the hormone receptor level in the liver occur only in male 
rats, and are accompanied by a reduction in the hepatic levels of other tes-
tosterone-inducible enzymes which metabolize estrogens. This process of the 
increase in serum estradiol level, an increase of ER and a reduction of ~ 
metabolizing enzyme system has been termed hepatic "feminization" (Eagon 
et aI., 1985; Francavilla et aI., 1986a) and appears to be a critical step in the 
overall process of hepatic regeneration for male animals. 
Estrogen-induced hepatocyte proliferation both in vitro and in vivo can 
be inhibited with the addition of tamoxifen, an anti-estrogen drug. When this 
drug is given i.p. to rats 6 h after a 70% PH, it completely inhibits DNA 
synthesis, whereas the simultaneous administration of estradiol completely 
blocks the growth inhibiting effect of tamoxifen administration (Francavilla 
et aI., 1989). 
It must be pointed out, however, that the relationship between steroidal 
sex hormones and hepatic regeneration remains difficult to understand fully, 
as the effect of these agents is seen only when hepatocytes from male rats 
are studied. The best current hypothesis is that in males, estrogens modulate 
epidermal growth factor- (EGF) -receptor expression to a level similar to that 
present in females and the interaction between EGF and its hepatic receptor 
is the crucial step in effecting a proliferative response (Francavilla et at., 
1987). 
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A similar relationship between EGF, its receptor, and estrogen have been 
shown to exist using breast cancer cells. In brea~t cancer cells. high estrogen 
receptor (ER) levels occur in association with low levels of EGF-Rs and 
reduced ER levels are associated with high EGF-R levels (Sainsbury et aI., 
1985). Moreover, experimental data obtained from patients with hepatocel-
lular carcinoma suggest that alterations in the estrogen/androgen (fiT) receptor 
ratio is actually more important than are the absolute changes in hormone 
levels or their receptors (Eagon et al.. 1991; Francavilla et aI., 1991b). An 
increase in the EIT ratio occurs during normal liver cell proliferation, whereas 
a reduction in this ratio is seen in neoplastic conditions. 
Thyroid Hormone, Norepinephrine, and Vasopressin 
When administered i .p., triiodothyronine (T .. ) stimulates liver cell mitoses 
in intact animals (Short et aI., 1972), whereas thyroidectomy. performed 7 
d prior to PH, results in a reduction in the subsequent regenerative response 
to a PH (Canzanelli et aI., 1949). In addition, TJ increases the number of 
mitoses present in the infused hepatic lobe with the PeS model of Starzl 
(Francavilla et aI., 1991a). However, TJ , when added to serum-free media 
in vitro. does not alter the proliferative activity of cultured liver cells. 
Norepinephrine is not mitogenic on its own as assessed using primary 
liver cells in culture. However, its interaction with ai-adrenergic receptors 
increases the hepatic regenerative response observed following EGF-stimu-
lated DNA synthesis, and is associated with a down-regulation of the EGF 
receptor on the surface of the liver cell (Cruise and Michalopoulos, 1985; 
Cruise et al.. 1986). Moreover, this particular neurotransmitter reduces the 
inhibitory effect ofTGF-p experienced by hepatocytes acting through an EGF-
independent pathway (Michalopoulos, 1990; Houck et al., 1988). 
The in vivo administration of prazosin. an al blocker. delays the peak. 
increase in DNA synthesis experienced following PH and is associated with 
an increase in the number of EGF receptors present on the surface of liver 
cells (Cruise et al., 1987). 
Finally, it should be noted that 2 h after a PH, norepinephrine blood 
levels increase substantially. Importantly, the increase in the norepinephrine 
level is considerably greater than that seen in sham-operated animals (Cruise 
et aI., 1987). 
Vasopressin. both in vitro and in vivo acts synergistically with other 
hormones to promote hepatocyte DNA synthesis (Russell and Bucher. 1983). 
Its hepatocyte-stimulatory activity depends upon binding of the hormone to 
specific receptors (Russell and Bucher, 1983b). After receptor binding, the 
vasopressin-receptor complex is internalized and the number of cell surface 
receptors for vasopressin is restored within 10 min, provided there are no 
additional hormonal stimuli. Intracellular transduction of the resultant vaso-
pressin-induced signal is dependent upon the phosphatidylinositol system 
(Fishman et a!.. 1985; Kirk et aI., 1977; Rozengurt et a!., 1979; Kirck et al.. 
1984; Exton, \988). 
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The role of vasopressin in the control of liver cell regeneration is con-
fInned further by the fact that the regenerative response following PH is 
impaired in the Battleboro rat, which is vasopressin deficient, and that the 
administration of exogenous vasopressin to Battleboro rats enhances the he-
patic regenerative response to PH (Russell and Bucher, 1983b). . 
Hepatic Growth Factors 
The hypothesis that hepatic regeneration is under the control of specific 
growth factors has stimulated considerable effort toward the identification 
and isolation of such factors. In this section, various factors which have the 
capability of stimulating (GSFs) or inhibiting (GIFs) hepatocyte proliferation 
are examined. 
Growth Stimulating Factors (GSFs) 
Hepatocyte Growth Factor (HGF) 
The identification and purification of this particular GF has been achieved 
almost simultaneously by Zamegar and Michalopoulos (1989) and by Nak-
amI11'\' et aI. (1986, 1987). HGF is known to be a protein composed of two 
subunits, a heavy and a light, which have molecular weights of 69 and 34 
kOa, respectively. It has been isolated from the serum of rats and man (Strain 
et aI., 1982; Michalopoulos et aI., 1983; Russell et aI., 1984; Thaler and 
Mich!liopoulos, ,1985; Ghoda et aI., 1988). The heavy chain is composed of 
foUr Kriglers, i.e., peptides with a double loop structure held together by 
three disulfide bonds (S-S) (Miyazawa et aI., 1989). The amino acid sequence 
of HGF has extensive homology with that of plasminogen 8nd with other 
catalytic and proteolytic substances present in blood (Strain et aI., 1982). 
Immunohistochemical studies have shown the presence of HGF in the thyroid 
gland, the brain, the pancreas, Bunner's glands of the duodenum and in the 
residual partially hepatectomized rat liver (Zamegar et aI., 1990). 
In vitro HGF is ten times more powerful as a growth promoter than is 
EGF. Moreover, it has been shown to produce morphological changes in 
hepatocytes consistent with hypertrophy (Francavilla et aI., 1991 a). Its growth 
promoting effect has been shown to be additive to that of EGF, and to be 
inhibitable by qdc-~ (Michalopoulos, 1990). Recently, it has been shown 
to be ,active also in vivo using the portacaval shunt model (Francavilla et al., 
1991a). 
Hepatopoietln 8 (HYfB) 
HPTB is a glycopeptide with a mol wt of 500 Da. It was first identified 
by Michalopoulos (Michalopoulos et aI., 1984). It has been shown to stimulate 
hepatOcyte proliferation in vitro by amplifying the proliferative response to 
EGF. No studies have been performed in vivo using this growth factor. 
321 
Heparin Binding Growth Factor-l (HBGF-l) 
HBGF-I is a heat-resistant substance having a mol wt of 16 kDa. It is 
produced by both parenchymal and nonparenchymalliver cells, and is active 
in vitro but not in vivo. and only in the presence of heparin (Kan et aI .• 1989). 
1?is characteristic identifies it as being completely different from hepatic 
stimulatory substance (HSS), which has a similar molecular weight and is 
also heat resistant, but is not active in vitro despite the presence of heparin 
(Francavilla et al.. 1987a, 199Ic). 
Transforming Growth Factor-a 
TGF-a is a 5.6-kDa protein consisting of a single chain of 50 amino 
acids (Marquardt et aI., 1984). Initially it was identified in cultures of tumor 
cells. More recently, TGF-a has been shown to be produced by normal cells 
both in vivo and in vitro (Mead and Fausto, 1989). It stimulates cell prolif-
eration through its interaction with the EGF receptor. In fact, its biological 
effect and the primary structure of TGF-a are quite similar if not identical 
to that of EGF (Marquardt et aI., 1984; Marquardt et aI., 1983; Derynck et 
aI., 1984; Derynck, 1988). TGF-a-mRNA expression increases in hepatocytes 
4 h after PH and reaches a maximal value 24 h after PH (Mead and Fausto, 
1989), points in time that correspond to the onset and peak mitotic activity 
seen after PH . 
Considering the role of TGF-a in the control of cell proliferation, Mead 
and Fausto (1989) have advanced the hypothesis that TGF-a is a major 
physiological stimulator of liver cell regeneration, and that it acts via an 
autocrine mechanism. Recently, using the portacaval shunt model TGF-a has 
been shown to be a potent in vivo stimulator of liver cell regeneration (Fran-
cavilla et aI., 199Ia). 
Epidermal Growth Factor (EGF) 
.Undoubtedly EGF is the best studied growth factor in terms of its ability 
to stimulate hepatocyte proliferation (Richman et aI., 1976; Earp and O'Keefe, 
1981; McGowan et aI., 1981; Rubin et aI., 1982; Francavilla et aI., 1986b; 
O'Connor-McCourt et aI., 1986; Goustin et aI., 1986; Olsen et aI., 1988; 
M~i et al., 1989). After the first demonstration of this behavior by Richman 
(Richman et aI., 1976) many subsequent in vivo and in vitro studies have 
been performed to assess the importance of this factor in the process of liver 
regeneration. 
EGF is a mitogenic factor for most if not all epithelial tissues which are 
particularly rich in their expression of EGF-specific receptors. The ability of 
EGF to stimulate liver cell proliferation in vitro is enhanced by the presence 
of insulin and the amino acid proline (McGowan et aI., 1981; Houck and 
Michalopoulos, 1985). Moreover, its effect is amplified when other GFs are 
added such as HGF, HBGF-I, and hematopoietin B (HPTB) (Michalopoulos, 
1990). 
In vitro EGF induces an internalization of its high-affinity cell surface 
receptor and the expression of low-affinity EGF receptors on the cell surface 
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(Wollenberg et aI., (989). This finding suggests that EGF and its low affinity 
receptor are important in the regenerative process. It also suggests the high 
affinity EGF receptor may serve only as a means of removing a surplus of 
EGF from the bloodstream and controlling (inhibiting) the mitogenic response 
of EGF (Wollenberg et aI., (989). 
The latter argument is supported by the clear-cut differences noted be-
tween male and female rats in terms of their hepatic EGF-Rs (Francavilla et 
aI., 1987). In fact, the pattern of EGF cell surface receptors in male rats after 
PH becomes similar to that of the female, where only low-affinity receptors 
are demonstrated (see the section on feminization). 
The importance of the observation of a reduction in the regenerative 
response of PH rats treated with anti-EGF antibodies or following the surgical 
removal of EGF-producing organs such as the duodenum (Olsen et aI., (988) 
has been deemphasized somewhat by the recent demonstration that the struc-
ture and biological characteristics of EGF and TGF-a are similar, EGF has 
been shown to have a rapid turnover, and EGF has been shown to be produced 
by many different organs (Elder et aI., 1978; Gregory et aI., 1979; Oka and 
Orth, 1983; Shikata et aI., 1984; Fallon et aI., 1984). 
Hepatic Stimulating Substance (HSS) 
HSS is a protein that has a mol wt ranging between 12 and 16 kDa. It 
is found in cytosolic extracts of rat (LaBrecque and Pesch, 1975; LaBrecque 
and Bachur, 1982; Francavilla et aI., 1987a, 1991c; LaBrecque et aI., 1987; 
LaBrecque et at 1987) rabbit (Fleig et aI., (986), and dog livers (Starzl et 
aI., (979) undergoing a proliferative response. 
Its molecular structure has not yet been fully defined. This fact and the 
possibility that different investigators have used different species of the sub-
stance may explain why the results of different investigations studying this 
material occasionally appear to diverge. 
Both the HSS fraction purified 9000-fold by La Brecque et al. (1984) 
and the fractions isolated by Aeig et al. (1986), which have a lesser degree 
of purification, are active using normal hepatocytes or hepatoma cells studied 
in vitro. 
An HSS fraction purified about 380,OOO-fold was isolated by Francavilla 
et al. (l987a, 199Ic). This fraction is active only when administered in vivo 
and has been shown to be active both in the 40% hepatectomized rat model 
and in the PCS model (Francavilla et aI., 199Ia). In the latter model, it 
induces a proliferative response that exceeds that induced by insulin and other 
well-recognized growth factors, at a dose of 20 ng/kg/d. This highly purified 
fraction does not stimulate the proliferation of hepatocytes in vitro in the 
presence or absence of either EGF or heparin (Francavilla et aI., 1987a). 
Table 3 describes the physicochemical characteristics of HSS as currently 
recognized (Francavilla et aI., 1991c). 
Regeneratio/l 
TABLE 3 
Physicochemical Characteristics 
orHSS 
Mol WI 14-16 kDa 
Enzymatic sensibility 
Neuraminidase 
Trypsin + 
Chymotrypsin + 
Heat resistance 95°C for 10 min 
Cyc\osporin and FK 506 
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Very recently, CyA and FK 506, two immunosuppressive agents which 
specifically inhibit T lymphocytes have been shown to be able to enhance 
hepatocyte proliferation in vivo. Makowka et al. (1986) and Kim et al. (1988) 
have reported that CyA enhances the regenerative response induced by PH. 
Subsequently, it has been shown that FK 506 also stimulates hepatic regen-
eration following a PH in rats (Francavilla et aI., 1989b). The stimulatory 
activity achieved with FK 506 is greater than that obtained with CyA and is 
organ specific, as it does not alter the proliferative response of the kidney 
following a unilateral nephrectomy or that of a remnant intestine after a 40% 
bowel resection (Francavilla et aI., I 990b). It appears as if at least some of 
the beneficial properties of FK 506 as compared to Cy A in liver transplantation 
are likely to be a result of the effect of FK 506 on hepatocyte proliferation. 
The hepatocyte stimulatory effect of CyA and FK 506 does not depend 
on the immunosuppressive properties of these agents (Francavilla et aI., 1991d). 
Whatever the mechanism for the proliferative effect of these agents might 
be, it clearly is not a result of a direct effect on hepatocytes as both agents 
do not stimulate proliferation of cultured hepatocytes either in the presence 
or absence of EGF (Francavilla et aI., 1990b). 
Growth Inhibiting Factors 
Only a small number of substances have been identified as being inhibitors 
of hepatocyte proliferation. 
Transforming Growth cactor·~ 
TGF-j3 is a 25-kDa homodimer produced by endothelial cells E~rau~ et 
aI., 1988). It inhibits both EGF and TGF-a stimulated hepatocyte prohferatlon 
in vitro (Nakamura et aI., 1985; Carr et aI., 1986; McMahon et aI., 1987). 
An injection of TGF-j3 into rats at the time of PH and II h later completely 
inhibits hepatocyte DNA synthesis for 24 h (Russell et aI., 1988). Figure 4 
shows the TGF-j3 mRNA content in rat liver after a PH. 
The gradual increase in TGF-j3 level noted after PH, together with its 
potent inhibitory activity on hepatocyte proliferation in vitro .. led Kca~s~o and 
Mead (1989) to hypothesize that this substance is a phYSIOlogical mhlbltor of 
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Figure 4. qdc-~ mRNA in regenerating rat liver. The relative content refers to the amount of 
qdc-~ I mRNA present in liver from sham-operated rats. 
liver cell regeneration which exerts its inhibitory effect via a paracrine 
mechanism. 
TGF-f3 is also a potent inhibitor of the regenerative response of cells 
found in other organs, including those of the immune system (Goustin et al., 
1986; Roberts et aI., (985). 
It has been reported that hepatocytes become TGF-f3 resistant after a PH. 
This topic was debated exhaustively in two monographs (Fausto, J 990; Mich-
alopouJos. 1990). 
. Considering the emerging relationships between the immune system and 
hver cell regeneration. it is possible that TGF-f3 represents a link(s) netween 
these two organ systems. 
Kupffer Cell Hepatocyte Inhibitor (KCHI) 
This factor is produced by Kupffer cells in vitro and is released into the 
culture medium 6 h postplating. It induces a 50% reduction in the proliferative 
activity of hepatocytes incubated in the presence of insulin independent of 
the presence or absence of EGF. 
This hepatocyte-inhibitory effect is reversible with removal of the material 
from the medium. Preliminary studies on the physicochemical characteristics 
of KCHI have shown that it has a mol wt ranging between 10 and 50 kDa 
~nd that it is sensitive to heat and a pH >8. These characteristics distinguish 
It from TGF-f3, tumor necrosis factor (TNF), and interleukin-I (IL- J) (Fran-
cavilla et aI., (988). 
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IL-l and IL-6 
IL-I inhibits in I'ivo hepatocyte DNA synthesis and enhances the expres-
sion of genes responsible for acute phase protein synthesis. Thus, IL-I pre-
vents liver cell mitosis and enhances reprogramming of the anabolic activity 
of the cell toward the production of acute phase proteins (Nakamura et aI., 
(988). The activity of IL-6 as a growth inhibitor is a matter of considerable 
debate (Henney. 1989; Mizel. 1989). 
Hepatocyte Proliferation Inhibitor (HPJ) 
This protein has a mol wt of 15 kDa. It differs physiochemicaHy from 
TGF-f3 in that it inhibits hepatocyte proliferation ill l'il'O as well as the pro-
liferation of other epithelial cells (Huggett et a!.. 1987), 
Rapamycin 
RPM is a potent immunosuppressive drug that disrupts normal signal 
transduction processes and inhibits hepatocyte proliferation ill vivo and in 
I'itro (Francavilla et al.. 1992b. 1992c) at levels not associated with inherent 
cytotoxicity for rat hepatocytes cultured either in conventional medium or in 
a medium enriched with EGF (Francavilla et aI., 1992a). The antiproliferative 
effect of RPM is dose dependent and long lasting after only a brief exposure, 
Moreover. the effect is unaltered by the concomitant presence of FK 506 in 
the medium and is uninfluenced by the presence of EGF in the medium, 
suggesting that there is a separate RPM binding protein may be involved in 
its action. 
DIETARY MANIPULATIONS AND LIVER CELL 
REGENERATION 
It is well known that feeding habits influence liver cell proliferative 
activity acting through their effect upon circadian rhythms. Moreover. ex-
perimental dietary manipulations have been shown to induce profound changes 
in the proliferative response of cells. 
Rats fed a protein-free diet for 3 d and then given an oral amino acid 
bolus (casein hydrolysate 2.5 g/5 ml tap water per rat) demonstrate are· 
markable increase in DNA synthesis activity (15-fold over that seen in normal 
animals). which is followed by a peak in mitotic activity (Bucher et al.. 
1978b). This increase in DNA synthesis is similar to the increment in DNA 
synthesis induced by PH. The only difference is that the peak of DNA in 
animal synthesis refeeding with amino acids occurs 4 h earlier than that seen 
after a PH. This is probably due to the fact that hepatocytes fed a protein-
free diet for 3 d are in G, phase as demonstrated by the behavior of the 
protooncogenes ('-my£' and ('-los. markers of this particular phase of the cell 
cycle IHorikawa et al.. 1986). 
i 
! 
I 
,I 
I 
HEPATIC REGENERATION AND LIVER 
TRANSPLANTATION 
With every liver transplant. some hepatic injury is experienced by the 
donor organ. For successful engraftment to occur. the hepatic injury must be 
balanced by an equal amount of hepatic regeneration. This regeneration is 
required to replace liver cells lost in the graft as a consequence of anyone 
or more of the following hepatic injuries: hypoxia, reperfusion. ischemia, or 
rejection. 
Moreover. because of a variety of surgical considerations. the donor organ 
is often smaller than the diseased resected native liver. As a result. the liver 
graft is often too small for the recipient's long-term metabolic needs and 
compensatory hyperplasia occurs with the liver graft growing at a rate of 100 
to 140 gld (Kam et al., 1987). This hepatic growth which is seen following 
liver transplantation is probably the result of many different factors including 
the following: a-adrenergic stimulation, release of endogenous hepatic growth 
factors that act via autocrine and paracrine pathways. and CyA- or FK 506-
induced growth stimulation. 
Evidence for chronic low grade but nonetheless continued regeneration 
of liver grafts following transplantation is demonstrated by the findings of 
thickened hepatic plates and nodular hepatic regeneration occurring in the 
absence of hepatic or portal fibrosis in well-tolerated long-term successful 
grafts (Van Thiel et al.. 1987). Grafts adversely affected by rejection show 
even greater degrees of hepatic regeneration with nodule formation, bile 
ductular proliferation, and bridging scars that can simulate cirrhotic nodules 
(Van Thiel et aI., 1987). 
Thus. some degree of hepatic regeneration occurs with every liver trans-
plant. The degree to which this regeneration process is manifest. however. 
is often inversely related to the degree of adversity experienced by the graft. 
Hepatic Regeneration in Humans 
We have recently shown that thymidine kinase (TK) and ornithine de-
carboxylase (ODC) activities in plasma reflect changes occurring during liver 
regeneration. Following a 70% PH in rats, the levels of these two enzymes 
provide a practical and noninvasive method for monitoring liver regeneration 
(Polimeno et al.. 1991). Similar observations have been made in humans 
(Francavilla et al.. 1990a). In the patients studied, a significant increase in 
the serum level of ODC. an enzyme required for increased polyamine synthesis 
(McCann, 1980; Bachrach. 1980; Russell, 1980). was seen 24 h after partial 
hepatectomy (McCann, 1980; Bachrach. 1980; Russell. 1980). An increase 
in ODC activity was seen 3 or 4 d later followed by a significant increase in 
the activity of TK, a marker of DNA synthesis. The sequential appearance 
in blood of ODC and TK was similar but delayed in comparison with these 
in experimental animals. In rats, the interval between the early activity of 
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ODC and the subsequent increases of TK is only 8 h (Polimeno et al.. 1991 I. 
In dogs (Francavilla et al., 1978) and pigs (Kahn et al.. 1980) the progression 
of these changes is slower, and in humans. 3 or 4 d seem to e)(ist between 
the resection and the initial regenerative events, signaled by the increase in 
ODC activity and the wave of DNA synthesis assessed by the level of TK in 
serum. This slower pace of liver regeneration in man can be documented also 
by CT scan studies that show that hepatic regeneration following a major 
hepatic resection is not complete until 3 weeks after the surgery, as opposed 
to 8 to 10 d in the rat <Bucher and Malt. 1971) and 14 d in the dog (Francavilla 
et al.. 1978) 
Changes in pancreatic hormone levels such as insulin and glucagon follow 
a more protracted schedule in humans as opposed to animals subjected to a 
PH. Avid insulin-binding to hepatocytes. with a subsequent decline in plasma 
insulin levels. occurs within 12 h in rats (Pezzino et al.. 198 n. but is not 
seen in patients, probably because the baseline glucagon level is four times 
greater in patients undergoing major hepatic surgery than those noted in 
normal. In contrast. changes in the se)( hormone levels in the blood of men 
studied after PH occurs briskly are evident within a few hours (Francavilla 
et al.. 1989a) and compatible with that reported in e)(pcrimental animals 
(Francavilla et al.. 1986a). 
GENERAL CONSIDERATIONS 
Current knowledge does not enable us to provide a comprehensive and 
fully integrated picture of the role that different factors play in the process 
of hepatic regeneration. This is true for the following reasons. 
The precise sequence and function of each of the currently recognized 
GSF and GIFs is not known. Worse yet. the crucial linking steps required 
for such an integrated understanding may reside in as-yet unrecognized GFs. 
Major difficulties are experienced when one selects a specific model for 
evaluating the behavior of growth factors. Each model has different require-
ments and the various GSF and GIFs have different mechanisms and playa 
role at unique time points in the overall sequence of events that occurs after 
a PH In any given model, the sequence and therefore the requirement for a 
given CiSI; and Glf' may difler. 
It is current I! unknown whether the humoral or the cellular events ob-
served following a partial hepatectomy are more important in initiating and 
sustaining the observed proliferative response. 
It is unclear whether the liver utilizes different proliferative pathways to 
compensate for a sudden loss of hepatic mass occurring as a result of a PH 
and the lesser loss of hepatic mass seen clinically after e)(posure either to a 
chemical or viral agent that occur over a prolonged period of e)(IXJsure. 
Fausto and Mead ( 198Y) have classified GFs into two major groups: those 
that act as priming factors. and those that act as progression factors. Priming 
PO~ Moleclliar and Cell /JIOI08Y oJ the LIl'l'r 
TABLE 4 
Michalopoulos Classification of 
Liver Growth Stimulators 
Comitogenic 
Complete Hepatocyte Mitogens Growth Factors 
• Epidermal growth factor • Norepinephrine 
(EGF) 
• Transforming growth factor a • Vasopressin 
(TGF-a) 
• Hepatopoietin A • Estrogen 
(HPTA) 
• Hepatopoietin B 
(HPTB) 
• Heparin binding growth factor-' • Insulin 
(HBFG-I) 
factors induce the transition from Go to G, in the cell cycle both in vim and 
in vitro. In contrast, progression factors stimulate the transition from G, to 
S and completion of the cell cycle. Although this distinction between types 
of growth factors is higly speculative, it has enabled investigators to identify 
two phases within the cell cycle (priming and progression) on the basis of 
variations in liver cell protooncogene expression (Fausto and Mead, 1989). 
Increases in the intracellular expression of myc and fos are features typical 
of the priming phase. The best model for the demonstration of these phe-
nomena is the 3-d protein-free diet (Horikawa et aJ.. 1986). 
A different classification of growth factors has been proposed by Mich-
alopoulos (1990). He made a distinction between complete and incomplete 
mitogens, based upon the ability of the agent in question to elicit a proliferative 
response in serum-free medium when studied in vitro, or whether the agent 
simply amplifies the proliferative response initiated by other growth factors 
that are essential for a response to occur. Table 4 identifies the currently 
recognized growth factors segregated according to the classification of Mich-
alopoulos. It is important to remember that this classification can be applied 
only to experiments performed in vitro, and is not applicable to in vivo models. 
This fact underlies the most serious limitation of our current understanding 
of the mechanisms regulating hepatic regeneration. e.g .. an ideal ill vivo 
model does not exist. Each model has its own unique characteristics and 
problems. 
For instance, even though the PH model has made it possible to identify 
the various hormonal changes that occur after a PH, it has not allowed us to 
determine with any confidence the meaning of these events. In fact, the 
changes observed for insulin and glucagon which have been recognized as 
being important are actually a result of the 70% hepatectomy per se and are 
not essential to the process of hepatic regeneration. In fact, the simple admin-
istration of glucose prevents PH-induced hypoglycemia in fasted animals. and 
as a result the hormonal changes typically observed after a PH do not occur. 
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and yet the pattern of hepatic regeneration remains unaltered (Caruana et al.. 
1981 ). 
It is generally believed that the increase in plasma norepinephrine levels 
seen immediately after a PH sensitizes hepatocytes to mitogenic stimulation 
by various growth factors present in the very early phase of the hepatic 
regenerative process following PH (Cruise et aI., 1987). In contrast. the 
increase in serum estradiol levels and the reduction in testosterone levels seen 
after a PH in both male rats and in human men (Francaville et al.. 1986a) 
appears to be required somewhat later in the regenerative process when sta-
bilization of the EGF receptor system is crucial and determines the subsequent 
regenerative response in the two sexes (Francavilla et al.. 198711). Similarly, 
a role in the regenerative process is played by T, which can be shown to 
stimulate regeneration in intact animals and following a PCS. In recent ex-
periments performed using the PCS dog model (Figure 2). the activity of all 
the hormones identified as stimulators of liver regeneration has been deter-
mined (Francavilla et al.. 199Ia). In Table 5 the results for each honnone 
are shown. In this model, the only hormones active were insulin and T,. This 
model demonstrates also that substances such as EGF, HGF. TGF-a, and 
IGF-I1 and HSS each stimulate hepatocyte proliferation in \'im in a dose-
response manner (Table 6). 
Most importantly, this model has confirmed the stimulatory activity of 
HSS. FK 506, and of CyA (Mazzaferro et aI., 1990), each of which has been 
shown to be active in the 40% hepatectomized rat model (Makowka et al.. 
1986; Francavilla et aI., 1987a. 1989b). Insulin, HSS. and the two immu-
nosuppressive agents. CyA and FK 506, are substances which would clearly 
have gone unrecognized as regeneration promoters without this model. Be-
cause of the unique characteristics and behavior of these substances they have 
been termed by us to be augmenters of hepatic regeneration (Francavilla et 
aI., 1991 a). 
The negative results obtained using the PCS model with various hornlOnes 
which have been shown to be active in vitro may be a result of the fact that 
these hormones are initiators of regeneration. As proposed by Fausto and 
Mead (1989). initiators induce the transition of hepatocytes from Gil to G, 
which occurs within a few hours of hepatic injury or cell loss. In the PCS 
model. proliferative activity (hepatic regeneration response) can only be as-
sessed after a 4-d infusion. then it represents a system in which spontaneously 
activation by endogenous initiating factors present in the liver or the blood 
have already exerted their effect. Thus, the various ions. nutrients, and reg-
ulators which test negatively in the PeS model probably are active as initiators 
and are undetected by this model. 
While it is evident that much remains to be learned about the events 
governed by growth factors. it is becoming increasingly obvious that the liver 
still has many remaining secrets; i.e., its ability to recover its mass utilizing 
different proliferative patterns and its relationship with the immune system 
are but only two examples. 
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Figure 5. Schematic representation of stem cells (oval cells) at the level of the tran,itional duct. 
Post-hepatectomy regeneration involves all of the hepatocytes within the 
liver (Fabrikant, 1969; Tsanev, 1975; Wright and Alison, 1984). Specifically 
all of the remaining liver cells following a PH are altered and express pre-
viously unexpressed protooncogenes (jos. myc P53, K-ras and H-ras. and 
heat-shock and drug-resistance genes) (Fausto and Mead. 1989; Cairo et at.. 
1985). while the hepatic regeneration observed after either a chemical-induced 
injury or after exposure to a viral agent is characterized by the occurrence of 
foci of a-fetoprotein and a-fetoprotein RNA-rich cells which express pro-
tooncogene markers typical of immature hepatocytes (Sell and Salman. I (84). 
These cells appear to be derived from a single stem cell (the oval cell) located 
principally at the junction of Hering's canals and the intralobular bile capil-
laries (transitional duct) (Figure 5) (Sell, 1990). 
The relationship that exists between the immune system and hepatic 
regeneration was identified as a result of the following experimental obser-
vations: DNA synthesis increases in lymphoid tissue after a PH (Sakai et at.. 
1976); rat serum obtained after a PH stimulates Iymphoidal proliferation (Sakai 
et aI., 1976); splenectomy augments hepatic regeneration (Perez-Tamayo and 
Romero, 1958); the administration of FK 506 and of CyA. two immunosup-
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pressive agents that specifically inhibit T-Iymphocytes. augment hepatic re-
generation (Makowka et al.. 1986; Francavilla et aI., I 990b, 1991d). 
Experiments performed in nude rats have ruled out a direct effect of 
immune modulation in the control of the regenerative process by T lympho-
cytes and natural killer cells as an explanation for the stimulating effect of 
FK 506 and eyA. As a result an alternative hypothesis has gained currency 
(Francavilla et aI., 199Id). The cytosolic receptors for FK 506 and eyA are 
small molecular weight proteins collectively called immunophillins (Schrei-
ber. 1991). They modulate a wide variety of calcium-dependent signal trans-
duction pathways (Perez-Tamayo and Romero. 1958; Sakai et al.. 1976; Bierer 
ct al .. 1990). The interaction of these two agents with their specific receptors 
modulates immunophillin-mediated signal transduction that contributes to the 
process of liver cell proliferation. Additional evidence relative to this issue 
comes from the recently observed effect of RPM on liver regeneration. Instead 
of promoting liver regeneration as occurs with FK 506 and eyA, RPM is 
antihepatotrophic (Francavilla et aI., 1992a and b). In rats submitted to a 
partial hepatectomy RPM inhibits liver regeneration instead of augmenting 
it. This observation constitutes the first physiologic evidence that the im-
munophillin network may playa key role in the interactions that exist between 
the immune system and growth control mechanisms (Starzl et at., 1990). 
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INTRODUCTION 
The liver parenchyma comprises several cell types. Parenchymatous cells 
or hepatocytes represent approximately 60% of liver cells. The nonhepatocyte 
cell population encompasses endothelial cells. Kupffer cells, fat-storing cells 
(also called stellate cells, adipocytes or Ito cells), Pit cells, and bile duct 
cells. Each cell population has defined functions. Interestingly, in some in-
stances, the hepatocyte and nonhepatocyte populations may interact, such as 
in the handling of vitamin A by fat storing cells and hepatocytes (DeWitt, 
1988). 
In this chapter, we shall address a different type of cell heterogeneity. 
There is evidence that there are phenotypic differences among hepatocytes 
(Traber et at.. 1988). These differences are due to the predominant. or some-
times exclusive. expression of proteins in certain hepatocytes. As a conse-
quence of the selective expression of proteins, function is compartmentalized. 
This phenomenon has been calIed hepatocyte heterogeneity, the subject of 
this review. Therefore. our objective is to describe the compartmentation of 
physiological processes in hepatocytes, to discuss its regulation. and finally, 
to attempt to elucidate its biological meaning. 
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